G1 Therapeutics Inc (GTHX)
4.53
-0.15
(-3.21%)
USD |
NASDAQ |
May 17, 16:00
4.53
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Free Cash Flow: -18.18M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -18.18M |
| December 31, 2023 | -38.34M |
| September 30, 2023 | -56.18M |
| June 30, 2023 | -66.85M |
| March 31, 2023 | -119.49M |
| December 31, 2022 | -129.13M |
| September 30, 2022 | -133.15M |
| June 30, 2022 | -145.99M |
| March 31, 2022 | -143.41M |
| December 31, 2021 | -132.11M |
| September 30, 2021 | -128.96M |
| June 30, 2021 | -91.24M |
| March 31, 2021 | -83.60M |
| December 31, 2020 | -83.74M |
| September 30, 2020 | -83.34M |
| Date | Value |
|---|---|
| June 30, 2020 | -113.33M |
| March 31, 2020 | -107.55M |
| December 31, 2019 | -102.29M |
| September 30, 2019 | -92.52M |
| June 30, 2019 | -83.39M |
| March 31, 2019 | -78.60M |
| December 31, 2018 | -75.02M |
| September 30, 2018 | -68.45M |
| June 30, 2018 | -65.22M |
| March 31, 2018 | -59.70M |
| December 31, 2017 | -50.81M |
| September 30, 2017 | -45.29M |
| June 30, 2017 | -36.71M |
| March 31, 2017 | -29.34M |
| December 31, 2016 | -25.39M |
Free Cash Flow Range, Past 5 Years
-145.99M
Minimum
Jun 2022
-18.18M
Maximum
Mar 2024
-97.64M
Average
-97.40M
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics Inc | -88.03M |
| Geron Corp | -184.70M |
| Palatin Technologies Inc | -26.75M |
| Oragenics Inc | -7.291M |
| TG Therapeutics Inc | 20.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.898M |
| Cash from Investing (Quarterly) | 5.289M |
| Cash from Financing (Quarterly) | -8.722M |
| Free Cash Flow Per Share (Quarterly) | -0.1706 |
| Free Cash Flow to Equity (Quarterly) | -0.434M |
| Free Cash Flow to Firm (Quarterly) | -7.201M |
| Free Cash Flow Yield | -7.40% |